絞り込み

16635

広告

「"O'Reilly T "[Author]」の検索結果

99件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Three-dimensional MRI in a homogenous 27 cm diameter bore Halbach array magnet.

How Much Knowledge Is Too Little? When a Lack of Knowledge Becomes a Barrier to Comprehension.

Deconstructing and reconstructing MRI hardware.

First-in-Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers.

Powerful turbidity currents driven by dense basal layers.

Media reporting of suicide and adherence to media guidelines.

Pharmacokinetic (PK) Drug Interaction Studies of Cabozantinib: Effect of CYP3A4 Inducer Rifampin and Inhibitor Ketoconazole on Cabozantinib Plasma PK, and Effect of Cabozantinib on CYP2C8 Probe Substrate Rosiglitazone Plasma PK.

Combined treatment strategies for microtubule stabilizing agent-resistant tumors.

Plasmonic Enhancement of Dye Sensitized Solar Cells via a Tailored Size-Distribution of Chemically Functionalized Gold Nanoparticles.

Chemistry of silica scale mitigation for RO desalination with particular reference to remote operations.

Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.

Research and innovation in the development of everolimus for oncology.

Th17 Cells, Not IL-17+ {gamma}{delta} T Cells, Drive Arthritic Bone Destruction in Mice and Humans.

Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis.

Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo.

Everolimus and PTK/ZK show synergistic growth inhibition in the orthotopic BL16/BL6 murine melanoma model.

A spatially resolved study on the Sn diffusion during the sintering process in the active layer of dye sensitised solar cells.

Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals.

Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Sort by
※並べ替えは表示に時間がかかります